# Kash Patel

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/kash-patel
Canonical HTML page: https://gethealthbrief.com/entity/kash-patel

## Timeline

- **2026-03-25**: New Federal Indictments — A major new wave of indictments is unsealed targeting specific citizens and firms for chemical delivery.
- **2023-06-23**: First Precursor Indictments — DOJ files first-ever charges against Chinese chemical companies for precursor trafficking.
- **2019-05-01**: China Schedules Fentanyl — China designates all fentanyl-related substances as controlled drugs following U.S. pressure.

## Recent coverage (2 stories)

### DOJ Charges 455 in $6.5B Healthcare Fraud Takedown Spanning 45 States
2026-06-28 18:03:40 · Sentiment: Neutral · Impact: 7/10 · Sources: 3

The DOJ’s 14-day operation charges 455 defendants for $6.5 billion in fraudulent claims, exposing schemes from medically unnecessary tests to international masterminds. The crackdown signals an aggressive new era of enforcement that could reshape compliance across the healthcare sector.
Full story: https://gethealthbrief.com/story/doj-455-charged-65-billion-healthcare-fraud-takedown

### DOJ Indicts Chinese Entities Over Fentanyl Precursor Chemical Supply Chain
2026-03-25 16:31:53 · Sentiment: Negative · Impact: 6/10 · Sources: 8

The U.S. Department of Justice has indicted multiple Chinese citizens and companies for allegedly supplying the precursor chemicals used to manufacture fentanyl. This enforcement action targets the international origins of the synthetic opioid crisis, signaling a more aggressive extraterritorial approach by federal law enforcement.
Full story: https://gethealthbrief.com/story/doj-indicts-chinese-fentanyl-precursors

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.